Medscape Perlmutter Cancer Center Radiation Oncologist Comments On A clinical trial shows that the addition of androgen deprivation therapy (adt) for 24 months is more effective than 6 months of hormone therapy in people with prostate cancer who have a radical prostatectomy and receive postoperative radiation therapy. results from the radicals hd study were reported at a presidential symposium during the 2022. Approached for comment on the new data, david j. byun, md, radiation oncologist, nyu langone perlmutter cancer center, new york city, explained that the current understanding of the.
Breast Cancer Medscape I'm a medical oncologist at the laura and isaac perlmutter cancer center in new york city at nyu langone health. i'd like to report to you today on three abstracts from the recent esmo. I'm a medical oncologist at the laura and isaac perlmutter cancer center at nyu langone health in new york city. today, i'll be reporting on a couple of abstracts related to adjuvant and. Our radiation oncologists helped pioneer prone breast external beam radiation therapy to treat breast cancer. this treatment directs radiation at the tumor from outside the body in a prone, or facedown, position, which allows for better distribution of the radiation dose and avoids contact with nearby organs, especially the heart. Dr. maya dimitrova, a medical oncologist at nyu langone’s perlmutter cancer center, discusses a promising new treatment for advanced melanoma. learn more.
Perlmutter Cancer Center Radiation Oncologist Works To Minimize Side Our radiation oncologists helped pioneer prone breast external beam radiation therapy to treat breast cancer. this treatment directs radiation at the tumor from outside the body in a prone, or facedown, position, which allows for better distribution of the radiation dose and avoids contact with nearby organs, especially the heart. Dr. maya dimitrova, a medical oncologist at nyu langone’s perlmutter cancer center, discusses a promising new treatment for advanced melanoma. learn more. A perlmutter cancer center clini cal trial led by radiation oncologist naamit gerber, md, to test whether a caffeine based cream reduces scar tissue formation from radiation. the hope is that the experimental remedy may improve the outcome of christa’s final breast reconstruction surgery, slated for later this year. christa’s cancer treatments. We are conducting a phase 2 clinical trial at perlmutter cancer center, called the redcoat study, to determine whether a topical caffeine cream can lower the risk of complications in women who need radiation therapy after having a mastectomy with breast reconstruction. the rates of reconstruction failure after a mastectomy are higher in women. In the trial, patients with high risk resected stage iiib iiic and iv melanoma were randomly allocated in a 2 to 1 ratio in a randomized phase 2 study to receive a neoantigen rna lipid encapsulated. In his new role, he will work with perlmutter cancer center’s urologic and medical oncology teams to develop a multidisciplinary approach toward diagnosis, treatment and management of.
Medscape Perlmutter Cancer Center Medical Oncologist Discusses A perlmutter cancer center clini cal trial led by radiation oncologist naamit gerber, md, to test whether a caffeine based cream reduces scar tissue formation from radiation. the hope is that the experimental remedy may improve the outcome of christa’s final breast reconstruction surgery, slated for later this year. christa’s cancer treatments. We are conducting a phase 2 clinical trial at perlmutter cancer center, called the redcoat study, to determine whether a topical caffeine cream can lower the risk of complications in women who need radiation therapy after having a mastectomy with breast reconstruction. the rates of reconstruction failure after a mastectomy are higher in women. In the trial, patients with high risk resected stage iiib iiic and iv melanoma were randomly allocated in a 2 to 1 ratio in a randomized phase 2 study to receive a neoantigen rna lipid encapsulated. In his new role, he will work with perlmutter cancer center’s urologic and medical oncology teams to develop a multidisciplinary approach toward diagnosis, treatment and management of.